Trade CERS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cerus Corporation (CERS) is trading at US$2.67, up 4.30% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$566.28M. Over the past 52 weeks, CERS has traded between US$1.38 and US$3.47. On Syfe you can trade CERS with $0 commission and add it to your watchlist.
| Previous close | US$2.56 |
|---|---|
| Market cap | US$566.28M |
| 52-week range | US$1.38 – US$3.47 |
| Volume | 3.81M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cerus Corporation
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Year: 1997
Cerus Signs Supply Agreement With French Blood Establishment for Intercept System
Apr 27, 2:23 PM · MT Newswires
Cerus Corporation (CERS) stock is trading at US$2.67, +4.30% from the previous close of US$2.56.
The market cap for Cerus Corporation (CERS) stock is approximately US$566.28M.
The 52-week high for Cerus Corporation (CERS) stock is US$3.47.
The 52-week low for Cerus Corporation (CERS) stock is US$1.38.
Cerus Corporation (CERS) does not currently pay a dividend.
Stay on top of CERS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
